Michael Canney Email

Chief Scientific Officer . Carthera

Current Roles

Employees:
28
Revenue:
$2.7M
About
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since 2010. The company's proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain. A Phase 1/2a clinical trial is underway in glioblastoma while the new treatment option could be suitable for a wide range of other indications, including Alzheimer's disease.
Carthera Address
Hopital Pitie Salpetriere
PARIS, null
France
Carthera Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.